On July 26, the adenovirus vector recombinant new crown vaccine for nebulization developed by the team of Academician Chen Wei of the Academy of Military Sciences of the Academy of Military Sciences published clinical research data in the famous international academic journal "The Lancet · Infectious Diseases", which is also the world The first publicly published results of the mucosal immunity clinical trial of the new crown vaccine
The research results show that the safety of nebulized inhalation vaccination is good, and there is no local adverse reaction of intramuscular injection
CCTV reporter Su Zhou exclusively visited a research institute of the Military Medical Research Institute and found that when researchers put the vaccine in the atomizer, the public does not need to be vaccinated by injection, but only needs to be inhaled through atomization.
Compared with the currently approved intramuscular vaccines, the difference between the vaccine for nebulization and inhalation is that the method of inhalation is adopted during vaccination, and the prescription, packaging form and production facilities of the vaccine are completely consistent with those for intramuscular injection
Hou Lihua, a researcher at the Academy of Military Medical Research of the Academy of Military Sciences, said that first, the vaccine does not require injections, and only needs to inhale to complete the vaccination.
It is understood that this clinical trial was launched in Wuhan in September 2020, co-hosted by the Academy of Military Medical Sciences and Zhongnan Hospital of Wuhan University
Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
